Zapomeran

泽波米瑞

Report date: 2026/05/13 11:17:47

Base Information

Drug NameZapomeran
Drug Alias NameARCT-154 Self-Amplifying RNA SARS-CoV-2 VaccineVBC-COV19-154KostaiveARCT-154ARCT154
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2023/11/28
Country/TerritoryUnited StatesVietnamSingapore +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesArcturus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics IncSeqirus Netherlands BvVinbiocare Biotechnology Joint Stock Company
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A